Finnegan Frederick 4
4 · SAB Biotherapeutics, Inc. · Filed Mar 18, 2022
Insider Transaction Report
Form 4
Finnegan Frederick
Chief Business Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-03-16+23,453→ 23,453 totalExercise: $1.78Exp: 2032-03-16→ Common Stock (23,453 underlying)
Footnotes (2)
- [F1]Represents options to purchase shares of common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan.
- [F2]The shares underlying the option will vest in full on the one-year anniversary of March 16, 2022, the date the award was approved by the Company's board of directors.